Nov 05, 2020
17:45 CET - ROTTERDAM, The Netherlands
IMCD to acquire the API business of Peak International
IMCD N.V. (“IMCD”), a leading distributor of speciality chemicals and ingredients, today announces that it has successfully signed an agreement to acquire the pharmaceutical business of Peak International Products B.V. (“Peak International”).
Peak International is a Dutch-based distributor in the active pharmaceutical ingredients (“API”) business for Benelux, Vietnam, Germany and Israel. The Peak pharmaceutical business generated a revenue of approx. € 5.8 m in 2019.
Lodewijk Mellema, Managing Director IMCD Benelux, comments: ‘With this acquisition IMCD expands its active pharmaceutical ingredients business primarily in Benelux and Vietnam and strengthens our company’s formulation and marketing synergies between active pharmaceutical ingredients and excipients in those regions”.
Erik van den Sigtenhorst, CEO Peak International, adds: “I am excited about the prospective of coupling Peak’s position in active pharmaceutical ingredients with IMCD’s geographic coverage, laboratory network and excellence in distribution of excipients. Our existing and future partners will be able to benefit from a significantly increased network within the pharmaceutical industry’’.
The acquired business will be integrated into IMCD Business Group Pharmaceuticals.
For further questions, please reach out to our Media Relations team.
To read the full press release, please click on the link below: